MedTrace Logo

Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults

NCT05847673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2024-07-19

No results posted yet for this study

Summary

This trial assesses the acceptability and preliminary efficacy of Empowered, Queer, Quitting, and Living (EQQUAL) smoking-cessation intervention for sexual and gender minority young adult smokers. The prevalence of tobacco use among sexual and gender minority (SGM) young adults is more than twice as high as non-SGM young adults, suggesting that existing SGM-related disparities in tobacco use will persist well into the foreseeable future unless sustained efforts are undertaken to address them. EQQUAL is an online smoking cessation intervention designed specifically for SGM young adult smokers, and may help them quit smoking.

Conditions

  • Cigarette Smoking-Related Carcinoma

Interventions

BEHAVIORAL

Online Smoking Cessation Intervention

Receive EQQUAL A intervention

BEHAVIORAL

Online Smoking Cessation Intervention

Receive EQQUAL B intervention

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Health Promotion and Education

Receive motivational messages and smoking cessation information via SMS text messages

Sponsors & Collaborators

  • The Leonard and Norma Klorfine Foundation

    collaborator UNKNOWN

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Jaimee Heffner · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-20
Primary Completion
2024-06-13
Completion
2024-06-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05847673 on ClinicalTrials.gov